Prosecution Insights
Last updated: August 17, 2026

Examiner: WILSON, MICHAEL C

Tech Center 1600 • Art Units: 1632 1638

This examiner grants 41% of resolved cases

Performance Statistics

41.4%
Allow Rate
-18.6% vs TC avg
1,005
Total Applications
+17.5%
Interview Lift
1348
Avg Prosecution Days
Based on 934 resolved cases, 2023–2026

Rejection Statute Breakdown

4.4%
§101 Eligibility
15.9%
§102 Novelty
29.5%
§103 Obviousness
39.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17910776 METHODS FOR GENERATING ENGINEERED MEMORY-LIKE NK CELLS AND COMPOSITIONS THEREOF Final Rejection Dana-Farber Cancer Institute, Inc.
18437160 GENETICALLY MODIFIED MSC AND THERAPEUTIC METHODS Final Rejection The Regents of the University of California
17351113 METHODS FOR THE TREATMENT OF DANON DISEASE AND OTHER DISORDERS OF AUTOPHAGY Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17640585 DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLS Final Rejection The Regents of the University of Michigan
18838519 Cerebrovascular-Tumor-On-A-Chip Non-Final OA Ohio State Innovation Foundation
18619199 METHOD FOR INDUCING DEDIFFERENTIATION OF ADIPOCYTES Non-Final OA City University of Hong Kong
18033442 MOUSE MODEL FOR BIO-IMAGING OF INFLAMMATORY SIGNALS, PREPARATION METHOD THEREFOR AND USE THEREOF Final Rejection SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
17264752 GENE THERAPY METHODS TO CONTROL ORGAN FUNCTION Non-Final OA Cornell University
17345773 Methods for Cardiac Fibroblast Differentiation of Human Pluripotent Stem Cells Final Rejection Wisconsin Alumni Research Foundation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month